Please use this identifier to cite or link to this item:
Scopus Web of Science® Altmetric
Type: Journal article
Title: Lenalidomide maintenance treatment after imatinib discontinuation: results of a phase 1 clinical trial in chronic myeloid leukaemia
Author: Ross, D.
Pagani, I.
Irani, Y.
Clarson, J.
Leclercq, T.
Dang, P.
McLean, J.
Saunders, V.
Carne, L.
Reynolds, J.
Ritchie, D.
White, D.
Branford, S.
Hughes, T.
Yong, A.
Citation: British Journal of Haematology, 2019; 186(3):e56-e60
Publisher: John Wiley & Sons
Issue Date: 2019
ISSN: 0007-1048
Statement of
David M. Ross, Ilaria S. Pagani, Yazad D. Irani, Jade Clarson, Tamara Leclercq, Phuong Dang, Jennifer McLean, Verity A. Saunders, Lisa Carne, John Reynolds, David S. Ritchie, Deborah L. White, Susan Branford, Timothy P. Hughes, Agnes S. M. Yong
Abstract: Abstract not available
Keywords: chronic myeloid leukaemia; immunology; minimal residual disease; treatment-free remission
Rights: © 2019 British Society for Haematology and John Wiley & Sons Ltd.
RMID: 0030112062
DOI: 10.1111/bjh.15894
Grant ID:
Appears in Collections:Medicine publications

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.